caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1760401327

Linda HolmesANP

PRACTICEALASKA UROLOGICAL INSTITUTE PCSee all providers at this practice →
Nurse PractitionerAnchorage, AKI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
417
Unique beneficiaries
—
Total services
526
Distinct HCPCS
5
Medicare payment
$31K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 468 Nurse Practitioner providers in AK — top quintile (cohort median 229).
REFERRAL NETWORK

Where Linda Holmes's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Seattle, WA
52123
PROVIDENCE HEALTH & SERVICES WASHINGTON3976
William Clark
Urology · Anchorage, AK
3196
LORAN, KIM2341
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Seattle, WA
1628
Larry Daugherty
Radiation Oncology · Anchorage, AK
11109
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
178
Beneficiaries
—
Total drug cost
$26K
Distinct drugs
7
Brand share
23.0%
Top prescribed drugs
Tamsulosin Hcl63 claims
Finasteride31 claims
Mirabegron30 claims
Cephalexin17 claims
Levofloxacin15 claims
QUALITY · MIPS · 2024
Final MIPS score
90.9
Quality
70.1
Cost
83.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.67%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$26
Payment records
1
By payment type
Food and Beverage$26